Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Persistence of Menveo in Korean Infants
NCT02446691Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine in meningococcal infection, sponsored by GSK. Started Jul 2015; status: completed.
02
Drugs
Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT02446691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446691.